Insmed Inc (INSM)
68.15
-0.17
(-0.25%)
USD |
NASDAQ |
Nov 04, 16:00
68.45
+0.30
(+0.44%)
After-Hours: 20:00
Insmed Gross Profit Margin (Quarterly): 77.34% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 77.34% |
| June 30, 2024 | 76.79% |
| March 31, 2024 | 76.88% |
| December 31, 2023 | 77.96% |
| September 30, 2023 | 78.87% |
| June 30, 2023 | 78.51% |
| March 31, 2023 | 78.79% |
| December 31, 2022 | 77.96% |
| September 30, 2022 | 80.11% |
| June 30, 2022 | 74.86% |
| March 31, 2022 | 77.04% |
| December 31, 2021 | 76.32% |
| September 30, 2021 | 78.22% |
| June 30, 2021 | 76.11% |
| March 31, 2021 | 75.52% |
| December 31, 2020 | 73.77% |
| September 30, 2020 | 75.66% |
| June 30, 2020 | 76.59% |
| March 31, 2020 | 77.11% |
| December 31, 2019 | 80.95% |
| September 30, 2019 | 83.45% |
| June 30, 2019 | 83.59% |
| March 31, 2019 | 81.05% |
| December 31, 2018 | 75.36% |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.77%
Minimum
Dec 2020
80.95%
Maximum
Dec 2019
77.27%
Average
77.08%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | -- |
| Alnylam Pharmaceuticals Inc | 82.85% |
| Eli Lilly and Co | 81.02% |
| Bioventus Inc | 68.54% |
| Entrada Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -56.29% |
| Return on Invested Capital | -85.94% |
| Profit Margin (Quarterly) | -236.0% |
| Operating Margin (Quarterly) | -212.7% |
| Return on Net Operating Assets | -200.4% |